These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 32894600)

  • 1. Glucagon stimulation test as a possible predictor of residual β-cell function.
    Yoshida K; Urakami T; Morioka I
    Pediatr Int; 2021 May; 63(5):536-542. PubMed ID: 32894600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity.
    Fujioka Y; Okura T; Sumi K; Matsumoto K; Shoji K; Nakamura R; Matsuzawa K; Izawa S; Kato M; Taniguchi S; Yamamoto K
    J Diabetes Investig; 2018 Mar; 9(2):274-278. PubMed ID: 28494143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort study.
    Kondo Y; Satoh S; Osada UN; Terauchi Y
    Endocr J; 2015; 62(11):971-80. PubMed ID: 26249841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study.
    Ohbatake A; Yagi K; Karashima S; Shima Y; Miyamoto Y; Asaka H; Okazaki S; Kometani M; Kawashiri MA; Takeda Y; Yoneda T; Chujo D
    Diabetes Ther; 2019 Apr; 10(2):673-681. PubMed ID: 30788807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal.
    Pozzilli P; Raz I; Peled D; Elias D; Avron A; Tamir M; Eren R; Dagan S; Cohen IR
    Diabetes Care; 2014; 37(5):1384-91. PubMed ID: 24408401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes.
    Guglielmi C; Del Toro R; Lauria A; Maurizi AR; Fallucca S; Cappelli A; Angeletti S; Lachin JM; Pozzilli P
    Diabetes Metab Res Rev; 2017 Sep; 33(6):. PubMed ID: 28371189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
    Thivolet C; Marchand L; Chikh K
    Diabetologia; 2019 Apr; 62(4):593-597. PubMed ID: 30612138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
    Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
    Saisho Y; Kou K; Tanaka K; Abe T; Kurosawa H; Shimada A; Meguro S; Kawai T; Itoh H
    Endocr J; 2011; 58(4):315-22. PubMed ID: 21415555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients.
    Kielgast U; Asmar M; Madsbad S; Holst JJ
    J Clin Endocrinol Metab; 2010 May; 95(5):2492-6. PubMed ID: 20207828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.
    Blanco J; Jiménez A; Casamitjana R; Flores L; Lacy A; Conget I; Vidal J
    Surg Obes Relat Dis; 2014; 10(1):9-13; quiz 189-90. PubMed ID: 24342036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function.
    Alba M; Ahrén B; Inzucchi SE; Guan Y; Mallick M; Xu L; O'Neill EA; Williams-Herman DE; Kaufman KD; Goldstein BJ
    Diabetes Obes Metab; 2013 Dec; 15(12):1101-10. PubMed ID: 23782502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term glucagon stimulation test of C-peptide effect on glucose utilization in patients with type 1 diabetes mellitus.
    Mojto V; Rausova Z; Chrenova J; Dedik L
    Med Biol Eng Comput; 2015 Dec; 53(12):1361-9. PubMed ID: 26607818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.
    Vilsbøll T; Krarup T; Deacon CF; Madsbad S; Holst JJ
    Diabetes; 2001 Mar; 50(3):609-13. PubMed ID: 11246881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes.
    Muscelli E; Casolaro A; Gastaldelli A; Mari A; Seghieri G; Astiarraga B; Chen Y; Alba M; Holst J; Ferrannini E
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2818-26. PubMed ID: 22685234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
    Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
    Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of diabetes mellitus in cats cannot be predicted by the arginine stimulation test.
    Tschuor F; Zini E; Schellenberg S; Wenger M; Kaufmann K; Furrer D; Lutz TA; Reusch CE
    J Vet Intern Med; 2011; 25(1):83-9. PubMed ID: 21143647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.